Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $17,179 | 840 | 71.5% |
| Consulting Fee | $4,550 | 6 | 18.9% |
| Travel and Lodging | $1,065 | 4 | 4.4% |
| Honoraria | $900.00 | 1 | 3.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $252.17 | 13 | 1.1% |
| Education | $70.19 | 3 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech, Inc. | $4,954 | 7 | $0 (2018) |
| Biogen, Inc. | $1,460 | 56 | $0 (2024) |
| Genentech USA, Inc. | $1,052 | 50 | $0 (2024) |
| ABBVIE INC. | $966.07 | 53 | $0 (2024) |
| BANNER LIFE SCIENCES, LLC | $911.67 | 2 | $0 (2021) |
| UCB, Inc. | $864.33 | 38 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $819.65 | 47 | $0 (2024) |
| EMD Serono, Inc. | $728.81 | 37 | $0 (2024) |
| Eisai Inc. | $633.14 | 27 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $556.28 | 25 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,893 | 112 | ABBVIE INC. ($342.29) |
| 2023 | $2,645 | 106 | Biogen, Inc. ($319.92) |
| 2022 | $1,884 | 104 | ABBVIE INC. ($190.87) |
| 2021 | $2,464 | 81 | BANNER LIFE SCIENCES, LLC ($911.67) |
| 2020 | $964.99 | 57 | Adamas Pharmaceuticals, Inc. ($137.12) |
| 2019 | $2,509 | 125 | Biogen, Inc. ($292.17) |
| 2018 | $8,039 | 166 | Genentech, Inc. ($4,916) |
| 2017 | $2,618 | 116 | UCB, Inc. ($360.84) |
All Payment Transactions
867 individual payment records from CMS Open Payments — Page 1 of 35
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $23.30 | General |
| Category: NEUROLOGY | ||||||
| 12/16/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: Neurology | ||||||
| 12/05/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $22.54 | General |
| 12/03/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $26.70 | General |
| Category: Rare Disease | ||||||
| 12/03/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/02/2024 | Genentech USA, Inc. | Ocrevus Zunovo (Biological) | Food and Beverage | In-kind items and services | $30.83 | General |
| Category: Immunology | ||||||
| 11/22/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: PAIN | ||||||
| 11/21/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $25.95 | General |
| Category: Immunology | ||||||
| 11/19/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: Neurology | ||||||
| 11/18/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $16.86 | General |
| Category: NEUROLOGY | ||||||
| 11/12/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $14.91 | General |
| 11/07/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: PSYCHIATRY | ||||||
| 11/05/2024 | MITSUBISHI TANABE PHARMA AMERICA, INC. | RADICAVA (Drug), RADICAVA ORS | Food and Beverage | In-kind items and services | $26.48 | General |
| Category: AMYOTROPHIC LATERAL SCLEROSIS | ||||||
| 11/04/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: Rare Disease | ||||||
| 11/01/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $272.78 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 10/31/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $26.54 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/22/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: PAIN | ||||||
| 10/17/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: Neurology | ||||||
| 10/15/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: Neurology | ||||||
| 10/08/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $26.35 | General |
| Category: Rare Disease | ||||||
| 10/07/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $19.57 | General |
| Category: NEUROLOGY | ||||||
| 10/04/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/03/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: IMMUNOLOGY | ||||||
| 10/01/2024 | Lilly USA, LLC | AMYVID (Drug), KISUNLA | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: Neuroscience | ||||||
| 09/30/2024 | Vanda Pharmaceuticals Inc. | PONVORY (Drug) | Food and Beverage | In-kind items and services | $24.60 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 633 | 774 | $183,548 | $77,566 |
| 2022 | 13 | 645 | 6,297 | $257,615 | $111,221 |
| 2021 | 11 | 692 | 885 | $214,336 | $93,323 |
| 2020 | 14 | 668 | 6,755 | $270,325 | $105,491 |
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 168 | 231 | $55,314 | $28,619 | 51.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 139 | 159 | $28,991 | $12,503 | 43.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 92 | 92 | $31,372 | $11,532 | 36.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 68 | 87 | $18,183 | $7,853 | 43.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 55 | 77 | $10,934 | $4,625 | 42.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 13 | 28 | $15,848 | $4,611 | 29.1% |
| 99483 | Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | Office | 2023 | 19 | 19 | $8,303 | $3,061 | 36.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 17 | 17 | $5,680 | $2,200 | 38.7% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 36 | 37 | $5,143 | $1,457 | 28.3% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2023 | 26 | 27 | $3,780 | $1,105 | 29.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 167 | 228 | $53,352 | $28,707 | 53.8% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 11 | 5,500 | $66,000 | $26,901 | 40.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 115 | 144 | $24,624 | $11,381 | 46.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 65 | 68 | $23,188 | $9,535 | 41.1% |
| 99483 | Assessment of and care planning for impaired thought processing, typically 50 minutes | Office | 2022 | 50 | 50 | $21,850 | $9,066 | 41.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 63 | 98 | $20,482 | $7,641 | 37.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 45 | 45 | $14,985 | $6,636 | 44.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 41 | 65 | $9,230 | $3,507 | 38.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 12 | 19 | $10,754 | $3,212 | 29.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 21 | 21 | $5,502 | $2,314 | 42.1% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 26 | 27 | $3,753 | $1,125 | 30.0% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2022 | 17 | 17 | $2,380 | $748.99 | 31.5% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 12 | 15 | $1,515 | $447.15 | 29.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 154 | 227 | $53,118 | $29,277 | 55.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 115 | 118 | $40,238 | $17,784 | 44.2% |
About Dr. Lori Trefts, M.D
Dr. Lori Trefts, M.D is a Neurology healthcare provider based in Brunswick, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1306875117.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lori Trefts, M.D has received a total of $24,016 in payments from pharmaceutical and medical device companies, with $2,893 received in 2024. These payments were reported across 867 transactions from 71 companies. The most common payment nature is "Food and Beverage" ($17,179).
As a Medicare-enrolled provider, Trefts has provided services to 2,638 Medicare beneficiaries, totaling 14,711 services with total Medicare billing of $387,601. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Other Specialties Neurology
- Location Brunswick, GA
- Active Since 07/02/2006
- Last Updated 09/09/2015
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1306875117
Products in Payments
- OCREVUS (Biological) $5,642
- TYSABRI (Biological) $1,299
- BAFIERTAM (Drug) $911.67
- Briviact (Drug) $605.81
- GOCOVRI (Drug) $588.01
- UBRELVY (Drug) $504.20
- NUEDEXTA (Drug) $468.29
- ACTHAR (Biological) $460.74
- Fycompa (Drug) $452.91
- Reveal LINQ (Device) $440.19
- Aimovig (Biological) $430.13
- Hizentra (Biological) $397.07
- NURTEC ODT (Drug) $380.02
- ZEPOSIA (Drug) $379.91
- BOTOX (Biological) $357.35
- PURIFIED CORTROPHIN GEL (Drug) $344.00
- VNS Therapy (Device) $341.60
- KESIMPTA (Drug) $327.90
- APTIOM (Drug) $324.31
- ULTOMIRIS (Biological) $308.21
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Brunswick
Dr. Phillip Amodeo, M.d, M.D
Neurology — Payments: $37,145
Kathryn Seasholtz, Do, DO
Neurology — Payments: $208.97
William Stamey, Md, MD
Neurology — Payments: $86.57
Jacques Reynolds, D.o, D.O
Neurology — Payments: $18.61
Veronica Sanchez, Pt, Dpt, PT, DPT
Neurology
Dr. Elizabeth Mcnally, Dc. Dacnb, DC. DACNB
Neurology